Cambridge Isotope Laboratories, Inc. Announces (13)C Cascade Production Optimization at Ohio Plant

"As we work to increase our operations and capabilities for our customers we sometimes need to think creatively for better solutions. This project is an example of using different problem-solving methods to achieve a better operating production cascade," says Mike Steiger, VP of Project Engineering and Execution. "As we work to increase our operations and capabilities for our customers we sometimes need to think creatively for better solutions. This project is an example of using different...
Comunicato Precedente

next
Comunicato Successivo

next

"As we work to increase our operations and capabilities for our customers we sometimes need to think creatively for better solutions. This project is an example of using different problem-solving methods to achieve a better operating production cascade," says Mike Steiger, VP of Project Engineering and Execution.

CIL's isotope-separation facility houses the world's largest 13C and one of the world's largest 18O isotope-separation facilities. This facility also has the world's only commercial D2O enrichment columns. These factors allow CIL to continue to be the world's leading producer of stable isotopes and stable isotope-labeled compounds for analytical and research applications. Having process control of stable isotope starting materials ensures inventory of needed synthetic precursors and allows tight control over the product quality demanded by CIL.

About Cambridge Isotope Laboratories, Inc.

CIL is the world's largest manufacturer and global supplier of stable isotopes and stable isotope-labeled compounds used in research, environmental, neonatal, pharmaceutical, medical diagnostic, OLED, and industrial markets. CIL is an operating business owned by Otsuka Pharmaceuticals. The CIL business consists of two facilities in the Boston, MA, area; a large isotope-enrichment production plant in Xenia, OH; CIL China; CIL Canada; ABX in Dresden, Germany; and Eurisotop in Saclay, France.

Cambridge Isotope Laboratories, Inc. Announces (13)C Cascade Production Optimization at Ohio Plant

For more information on CIL, visit isotope.com.

Related Images

cambridge-isotope-laboratories-inc.jpg
Cambridge Isotope Laboratories, Inc. Announces 13C Cascade Production Optimization at Ohio Plant

Photo - https://mma.prnewswire.com/media/1386201/Cambridge_Isotope_Laboratories.jpg  

Per maggiori informazioni

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;